The bodies fight against cancer: Is human leucocyte antigen (HLA) class 1 the key?

Journal of Cancer Research and Clinical Oncology

Volumn 138, Issue 5, 2012, Pages 723-728

  Powell, Arfon G M T ^a   Horgan, Paul G ^b   Edwards, Joanne ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Cancer; HLA; Immune response

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA C ANTIGEN; HLA G ANTIGEN; ANTIBODY;

ANTIGEN EXPRESSION; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; DIGESTIVE SYSTEM CANCER; ENZYME ACTIVITY; ESOPHAGUS CANCER; HUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; STOMACH CANCER; SYSTEMATIC REVIEW; ANIMAL; EVALUATION; GASTROINTESTINAL TUMOR; GENETICS; IMMUNOLOGY; IMMUNOTHERAPY; METABOLISM; METHODOLOGY; NEOPLASM; PHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; VALIDATION STUDY;

ANIMALS; ANTIBODIES; GASTROINTESTINAL NEOPLASMS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOTHERAPY; NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; VALIDATION STUDIES AS TOPIC;

EID: 84862297781     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-012-1192-4     Document Type: Review

References (40)

1. Bar-Eli M, Battifora H, Cline MJ (1988) Alterations of class I HLA genes in human colon cancers. Hum Genet 78:86-89 (Pubitemid 18039533)
2. Benevolo M, Mottolese M, Piperno G, Sperduti I, Cione A, Sibilio L, Martayan A, Donnorso RP, Cosimelli M, Giacomini P (2007) HLA-A, -B, -C expression in colon carcinoma mimics that of the normal colonic mucosa and is prognostically relevant. Am J Surg Pathol 31:76-84 (Pubitemid 46036905)
3. Brodsky RM, Parham P, Barnstable C, Crumpton M, Bodmet W (1979) Monoclonal antibodies for analysis of the HLA system. Immunol Rev 47:3-61 (Pubitemid 10173014)
4. Cancerstats (2010) http://www.cancerresearchuk.org. Accessed 14 Feb 2012
5. Chatzipetrou MA, Tarassi KE, Konstadoulakis MM, Pappas HE, Zafirellis KD, Athanassiades TE, Papadopoulos SA, Panousopoulos DG, Golematis BC, Papasteriades CA (1999) Human leukocyte antigens as genetic markers in colorectal carcinoma. Dis Colon Rectum 42:66-70 (Pubitemid 29053122)
6. Crumley AB, Going JJ, Hilmy M, Dutta S, Tannahill C, McKernan M, Edwards J, Stuart RC, McMillan DC (2011) Interrelationships between tumor proliferative activity, leucocyte and macrophage infiltration, systemic inflammatory response, and survival in patients selected for potentially curative resection for gastroesophageal cancer. Ann Surg Oncol 18:2604-2612
7. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pagès C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohoué F, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Pagès F (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313:1960-1964 (Pubitemid 44498003)
8. Goepel JR, Rees RC, Rogers K, Stoddard CJ, Thomas WE, Shepherd L (1991) Loss of monomorphic and polymorphic HLA antigens in metastatic breast and colon carcinoma. Br J Cancer 64:880-883
9. Hosch SB, Meyer AF, Schneider C, Stoecklein N, Prenzel KL, PantelK, Broelsch CE, Izbicki JR (1997a) Expression and prognostic significance of HLA class I, ICAN-1, and tumor-infiltrating lymphocytes in esophageal cancer. J Gastrointest Surg 1:316-323 (Pubitemid 127432776)
10. Hosch SB, Izbicki JR, Pichlmeier U, Stoecklein N, Niendorf A, Knoefel WT, Broelsch CE, Pantel K (1997b) Expression and prognostic significance of immunoregulatory molecules in esophageal cancer. Int J Cancer 74:582-587 (Pubitemid 28037498)
11. Ishigami S, Natsugoe S, Nakajo A, Arigami T, Kitazono M, Okumura H, Matsumoto M, Uchikado Y, Setoyama T, Sasaki K, Aikou T (2008) HLA-class 1 expression in gastric cancer. J Surg Oncol 97:605-608
12. Kaklamanis L, Gatter KC, Hill AB, Mortensen N, Harris AL, Krausa P, McMichael A, Bodmer JG, Bodmer WF (1992) Loss of HLA class-I alleles, heavy chains and beta 2-microglobulin in colorectal cancer. Int J Cancer 51:379-385
13. Kasajima A, Sers C, Sasano H, Jöhrens K, Stenzinger A, Noske A, Buckendahl AC, Darb-Esfahani S, Mü ller BM, Budczies J, Lehman A, Dietel M, Denkert C, Weichert W (2010) Downregulation of the antigen processing machinery is linked to a loss of inflammatory response in colorectal cancer. Hum Pathol 41:1758-1769
14. Klintrup K, Makinen JM, Kauppila S, Vare PO, Melkko J, Tuominen H, Tuppurainen K, Makela J, Karttunen TJ, Makinen MJ (2005) Inflammation and prognosis in colorectal cancer. Eur J Cancer 41:2645-2654 (Pubitemid 41607555)
15. Kloor M, Becker C, Benner A, Woerner SM, Gebert J, Ferrone S, von KnebelDoeberitz M (2005) Immunoselective pressure and human leukocyte antigen class 1 antigen machinery defects in microsatellite unstable colorectal cancers. Cancer Res 65: 6418-6424 (Pubitemid 40994430)
16. McArdle CS, Hole DJ (2002) Outcome following surgery for colorectal cancer: analysis by hospital after adjustment for case-mix and deprivation. Br J Cancer 86:331-335 (Pubitemid 34185112)
17. McMillan DC (2009) Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 12:223-226
18. Menon AG, Morreau H, Tollenaar RA, Alphenaar E, Van Puijenbroek M, Putter H, Janssen-Van Rhijn CM, Van De Velde CJ, Fleuren GJ, Kuppen PJ (2002) Down-regulation of HLA-A expression correlates with a better prognosis in colorectal cancer patients. Lab Invest 82:1725-1733 (Pubitemid 35462985)
19. Mizukami Y, Kono K, Maruyama T, Watanabe M, Kawaguchi Y, Kamimura K, Fujii H (2008) Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma. Br J Cancer 99:1462-1467
20. Möller P, Koretz K, Schlag P, Momburg F (1991a) Frequency of abnormal expression of HLA-A, B, C and HLA-DR molecules, invariant chain, and LFA-3 (CD58) in colorectal carcinoma and its impact on tumour recurrence. Int J Cancer Suppl 6:155-162
21. Möller P, Momburg F, Koretz K, Moldenhauer G, Herfarth C, Otto HF, Hämmerling GJ, Schlag P (1991b) Influence of major histocompatibility complex class I and II antigens on survival in colorectal carcinoma. Cancer Res 51:729-736
22. Momburg F, Ziegler A, Harpprecht J, Möller P, Moldenhauer G, Hämmerling GJ (1989) Selective loss of HLA-A or HLA-B antigen expression in colon carcinoma. J Immunol 142:352-358 (Pubitemid 19034765)
23. Perosa F, Luccarelli G, Prete M, Favoino E, Ferrone S, Dammacco F (2003) Beta 2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide. J Immunol 171:1918-1926 (Pubitemid 36966475)
24. Ropponen KM, Eskelinen MJ, Lipponen PK, Alhava E, Kosma VM (1997) Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol 182:318-324 (Pubitemid 27285785)
25. Roxburgh CSD, Salmond JM, Horgan PG, Oien KA, McMillan DC (2009) Tumour inflammatory infiltrate predicts survival following curative resection for node negative colorectal cancer. Eur J Surg 45:2138-2145
26. Seitz C, Uchanska-Ziegler B, Zank A, Ziegler A (1998) The monoclonal antibody HCA2 recognises a broadly shared epitope on selected classical as well as several non-classical HLA class I molecules. MolImmunol 35:819-827 (Pubitemid 28518384)
27. Sernee MF, Ploegh HL, Schust DJ (1998) Why certain antibodies cross-react with HLA-A and HLA-G: epitope mapping of two common MHC class I reagents. Mol Immunol 35:177-188 (Pubitemid 28319923)
28. Shen YQ, Zhang JQ, Miao FQ, Zhang JM, Jiang Q, Chen H, Shan XN, Xie W (2005) Relationship between the downregulation of HLA class I antigen and clinicopathological significance in gastric cancer. World J Gastroenterol 11:3628-3631 (Pubitemid 40903528)
29. Simpson JA, Al-Attar A, Watson NF, Scholefield JH, Ilyas M, Durrant LG (2010) Intratumoral T cell infiltration, MHC class I and STAT1 as biomarkers of good prognosis in colorectal cancer. Gut 59:926-933
30. Speetjens FM, de Bruin EC, Morreau H, Zeestraten EC, Putter H, van Krieken JH, van Buren MM, van Velzen M, Dekker-Ensink NG, van de Velde CJ, Kuppen PJ (2008) Clinical impact of HLA class I expression in rectal cancer. Cancer Immunol Immunother 57:601-609 (Pubitemid 351641023)
31. Stam NJ, Spits H, Ploegh HL (1986) Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J Immunol 137:2299-2306 (Pubitemid 16020728)
32. Stam NJ, Vroom TM, Peters PJ, Pastoors EB, Ploegh HL (1990) HLA-A- and HLA-B-specific monoclonal antibodies reactive with free heavy chains in western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopy. Int Immunol 2:113-125 (Pubitemid 20050409)
33. Stein B, Momburg F, Schwarz V, Schlag P, Moldenhauer G, Möller P (1988) Reduction or loss of HLA-A, B, C antigens in colorectal carcinoma appears not to influence survival. Br J Cancer 57:364-368
34. Ueda Y, Ishikawa K, Shiraishi N, Yokoyama S, Kitano S (2008) Clinical significance of HLA class I heavy chain expression in patients with gastric cancer. J Surg Oncol 97:451-455 (Pubitemid 351466390)
35. Vakilla J, Lotze MT (2004) Inflammation and necrosis promote tumour growth. Nat Cancer Rev 4:641-648 (Pubitemid 39025049)
36. Van den Ingh HF, Ruiter DJ, Griffioen G, van Muijen GN, Ferrone S (1987) HLA antigens in colorectal tumours-low expression of HLA class I antigens in mucinous colorectal carcinomas. Br J Cancer 55:125-130 (Pubitemid 17021672)
37. Watson NFS, Ramage JM, Madjd Z, Spendlove I, Ellis IO, Schofield JH, Durrant LG (2006) Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class 1 expression correlates with poor prognosis. Int J Cancer 118:6-10 (Pubitemid 41681574)
38. Ye SR, Yang H, Li K, Dong DD, Lin XM, Yie SM (2007) Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer. Mod Pathol 20: 375-383 (Pubitemid 46348337)
39. Yie SM, Yang H, Ye SR, Li K, Dong DD, Lin XM (2007a) Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric cancer. Ann Surg Oncol 14: 2721-2729 (Pubitemid 47460633)
40. Yie SM, Yang H, Ye SR, Li K, Dong DD, Lin XM (2007b) Expression of HLA-G is associated with prognosis in esophageal squamous cell carcinoma. Am J Clin Pathol 128:1002-1009